News
When the Covid-19 pandemic hit, the then-Stanford professor was one of the loudest critics of lockdowns, school closures and ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Explore more
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
The EU Court found the head of the European Commission, Ursula von der Leyen, responsible for concealing information about ...
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results